Cat /

Breed profile · FDA CVM July 2026 extract

Singapura adverse-event record

Adverse-event filings for Singapura (Cat) in the FDA Center for Veterinary Medicine openFDA extract. Browse cat breeds, reactions, and outcomes below.

#417 of 510
by report volume (all breeds)
13
FDA CVM reports on file
0.0%
death-coded share of reports
4
Lethargy (see also Central nervous system depression in Neurological) - top reaction

How the 13 reports break down

By recorded gender -- every report on file for Singapura, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 5 3.75 2.5 1.25 0 2012 2015 2019 2023 2024 Reports filed Death-coded reports
Annual report volume for Singapura drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Singapura ranks #412 of 510 by total reports (13). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#412
This breed, reports of 510

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Singapura has 13 reports now versus 13 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Singapura changes

Total Reports

13

Low report volume

Deaths Reported

0

of 13 reports

Death-coded share of reports

0.0%

0.0% death-coded

Avg Age at Report

7.1 yr

3.4 kg avg weight

Death-Coded Outcome Share

Singapura death-coded reports 0.0%
Cross-breed median

0.0% of 13 singapura reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 3.4 kg (7.5 lbs)

Top Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 4
Neutrophilia 3
Eosinophilia 3
Lack of efficacy - NOS 2
Limping 2

Most Referenced Drugs

Maropitant Citrate 5
Robenacoxib 4
Cefovecin 3
Prednisone 2
Cyclosporine 2

Outcome Breakdown

Ongoing
5 (38.5%)
Recovered/Normal
5 (38.5%)
Outcome Unknown
3 (23.1%)

Gender Distribution

Male 7 (53.8%)
Female 6 (46.2%)

Reports by Year

Year Reports Trend
2012 1
2015 1
2019 2
2023 4
2024 5

Singapura: low death-coded share in the FDA CVM extract

Signature read: 13 reports place Singapura in the lower third of breed filing volume (#417 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Singapura sits at #417 of 510 by report volume among all breeds and #50 of 55 among cat breeds, with 13 reports and 0 (0.0%) death-coded. Mean age at report: 7.1 years, average weight 3.4 kg (7.5 lbs).

Top reported signs: Lethargy (see also Central nervous system depression in Neurological) (4), Neutrophilia (3), Eosinophilia (3). Most-referenced drug: Maropitant Citrate (5 reports), followed by Robenacoxib (4) and Cefovecin (3).

Outcome coding on 13 status-recorded reports is dominated by Ongoing (38.5%). Annual submissions ranged 1-2,024 across 5 years on file.

Cat Breeds With a Similar Report Volume

Showing 6 of 54 cat breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Sparse-volume peer sets for Singapura drawn from openFDA outside the Cat family so the neighborhoods are not species containment (the similar-volume list above stays within species).

What to do with this cat

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Singapura?
There are 13 adverse event reports involving Singapura in the FDA database, of which 0 were death-coded (0.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Singapura ranks #417 of 510 by report volume among all breeds PlainBreed indexes (#50 of 55 among cat breeds).
Where does Singapura sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Singapura is #417 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Cat, it is #50 of 55. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Singapura?
The most commonly reported adverse reactions for Singapura are Lethargy (see also Central nervous system depression in Neurological) (4 reports), Neutrophilia (3 reports), Eosinophilia (3 reports), Lack of efficacy - NOS (2 reports), Limping (2 reports).
What drugs are most frequently associated with Singapura adverse events?
The drugs most frequently referenced in Singapura adverse event reports are Maropitant Citrate (5 reports), Robenacoxib (4 reports), Cefovecin (3 reports), Prednisone (2 reports), Cyclosporine (2 reports).
What is the average age of Singapura in adverse event reports?
The average age of Singapura at the time of adverse event reports is 7.1 years, with an average weight of 3.4 kg (7.5 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Singapura (Cat), extract as of July 2026 extract. 13 reports · 0 death-coded (0.0% of reports, not a mortality rate) · #417 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →